Page 5 - Jalan Lada News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Humanigen Announces Proposed Public Offering of Five Million Shares of Common Stock

Humanigen Announces Proposed Public Offering of Five Million Shares of Common Stock
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNorth carolinaJalan ladaCantor fitzgerald coGarnier coCredit suisseDrug administrationCredit suisse securities united statesOppenheimer coExchange commissionProspectus departmentEquity syndicate prospectus departmentNational securities corporationHumanigen incHc wainwright co

Sonnet BioTherapeutics Provides 2021 Business Update

Sonnet BioTherapeutics Provides 2021 Business Update
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Pankaj mohanJalan ladaExchange commissionSonnet biotherapeutics incSecurities exchangeSonnet biotherapeutics holdings incFully humanInduced peripheral neuropathPeripheral neuropathySouth east asiaNew life therapeuticsFully human albumin bindingSecurities actSecurities exchange actPrivate securities litigation reform actபங்கஜ் மோகன்

Sonnet BioTherapeutics Appoints Richard Kenney as Chief Medical Officer and Manuel Dafonseca as Head of Clinical Operations

Sonnet BioTherapeutics Appoints Richard Kenney as Chief Medical Officer and Manuel Dafonseca as Head of Clinical Operations
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United statesClinreg biologicsCrucell hollandPankaj mohanRichard kenneyJalan ladaManuel dafonsecaHarvard medical schoolExchange commissionRutgers universityGeorge washington universitySecurities exchangeSonnet biotherapeutics incSonnet biotherapeutics holdings incChief medical officerClinical operations

Sonnet BioTherapeutics Appoints Richard Kenney as Chief Medical Officer and Manuel Dafonseca as Head of Clinical Operations

Sonnet BioTherapeutics Appoints Richard Kenney as Chief Medical Officer and Manuel Dafonseca as Head of Clinical Operations
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Humanigen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

Press release content from Business Wire. The AP news staff was not involved in its creation. Humanigen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update March 10, 2021 GMT BURLINGAME, Calif. (BUSINESS WIRE) Mar 10, 2021 Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab™, today reported financial results for the year ending December 31, 2020 and announced objectives for 2021. “We are proud of all the advances Humanigen made in 2020, not just as a company, but as a key player in the development of an effective treatment for hospitalized COVID-19 patients,” said Cameron Durrant, MD, MBA, Chief Executive Officer, Humanigen. “We were able to take lenzilumab from the context of preventing and treating cytokine storm in other therapeutic categories and adapt it at unpr

United statesSouth koreaUnited kingdomCameron durrantEdward jordanBob atwillTimothy morrisJalan ladaDale chappellDevelopment agreementDepartment of defense doBiomedical advanced researchDevelopment authorityExchange commissionGilead companyHumanigen inc